Table 3.
Quality indicators for ovarian and cervical cancers; treatment years 2014–2019
| Indicator | 2019 median, absolute patient Nr overall proportion | 2018 median, absolute patient Nr overall proportion | 2017 median, absolute patient Nr overall proportion | 2016 median, absolute patient Nr overall proportion | 2015 median, absolute patient Nr overall proportion | 2014 median, absolute patient Nr overall proportion | C-A test | ||
|---|---|---|---|---|---|---|---|---|---|
| Ovarian Carcinoma | |||||||||
| 1 | Surgical staging of early ovarian carcinoma |
81.8% 504/630 80.0% |
85.7% 506/647 78.2% |
80.0% 485/617 78.6% |
85.7% 501/636 78.8% |
83.3% 473/603 78.4% |
75.0% 384/589 65.2% |
0.067 | |
| 2 | Macroscopic complete resection of advanced ovarian carcinoma |
75.0% 920/1269 72.5% |
68.3% 880/1275 69.0% |
69.6% 873/1231 70.9% |
70.0% 921/1318 69.9% |
62.5% 849/1345 63.1% |
58.8% 858/1406 59.9% |
0.002 | |
| 3 | Surgery for advanced ovarian carcinoma by a gynaecological oncologist |
100.0% 1191/1269 93.9% |
100.0% 1192/1275 93.5% |
100.0% 1089/1231 88.5% |
100.0% 1211/1318 91.2% |
92.3% 1166/1345 86.7% |
100.0% 1215/1406 86.4% |
0.077 | |
| 4s | Post-operative chemotherapy for advanced ovarian carcinoma |
88.9% 923/1130 81.7% |
90.9% 914/1117 81.8% |
90.0% 954/1081 88.3% |
91.7% 1031/1169 88.2% |
90.9% 1064/1191 89.3% |
94.6% 1157/1265 91.5% |
0.021 | |
| 5 | First-line chemotherapy for advanced ovarian carcinoma |
60.3% 957/1661 57.6% |
61.1% 968/1633 59.3% |
63.6% 1004/1559 64.4% |
60.0% 1014/1649 61.5% |
62.5% 1088/1669 65.2% |
69.2% 1113/1649 67.5% |
0.022 | |
| Cervical Carcinoma | |||||||||
| 6 | Presentation at the tumour board |
100.0% 1857/1913 97.1% |
100.0% 1716/1777 96.6% |
100.0% 1779/1865 95.4% |
100.0% 1695/1777 95.4% |
100.0% 1710/1793 95.4% |
n/a | 0.670 | |
| 7 | Details in the pathology report on initial diagnosis and tumour resection |
92.3% 798/874 91.3% |
78.4% 652/832 78.4% |
68.8% 612/879 69.6% |
75.3% 631/890 70.9% |
71.3% 648/889 72.9% |
n/a | 0.001 | |
| 8 | Details in the pathology report for lymphono-dectomy |
97.8% 652/669 97.5% |
95.0% 667/705 94.6% |
90.9% 683/743 91.9% |
89.6% 661/735 89.9% |
88.0% 706/794 88.9% |
n/a | 0.170 | |
| 9 | Cytological/histological lymph node staging |
72.9% 777/1028 75.6% |
78.2% 792/979 80.9% |
71.8% 774/1042 74.3% |
69.4% 819/1169 70.1% |
63.2% 718/1140 63.0% |
n/a | 0.009 | |
The median is based on the rate of the individual certified centre. The absolute number as well as the overall proportions are based on the cumulative data of all certified centres
C-A Test, Cochran-Armitage test for trend, p-value is reported